Personalized cancer medicine: next steps in the genomic era
- PMID: 25720594
- PMCID: PMC4359352
- DOI: 10.1007/s13402-015-0221-0
Personalized cancer medicine: next steps in the genomic era
Similar articles
-
[Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].Rinsho Byori. 2015 Oct;63(10):1188-93. Rinsho Byori. 2015. PMID: 26897855 Review. Japanese.
-
Surgical Oncology in the Age of Genomic Medicine.Surg Oncol Clin N Am. 2015 Oct;24(4):xiii-xv. doi: 10.1016/j.soc.2015.07.001. Epub 2015 Aug 13. Surg Oncol Clin N Am. 2015. PMID: 26363545 No abstract available.
-
Personalized cancer medicine and the future of pathology.Virchows Arch. 2012 Jan;460(1):3-8. doi: 10.1007/s00428-011-1179-6. Epub 2011 Dec 6. Virchows Arch. 2012. PMID: 22143935 Review.
-
[Personalized medicine: state-of-the-art and prospects].Vestn Ross Akad Med Nauk. 2012;(12):4-12. Vestn Ross Akad Med Nauk. 2012. PMID: 23530419 Russian.
-
Personalized medicine in cancer: where are we today?Future Oncol. 2015;11(20):2795-8. doi: 10.2217/fon.15.204. Epub 2015 Sep 7. Future Oncol. 2015. PMID: 26344657 No abstract available.
Cited by
-
NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy.Cell Oncol (Dordr). 2016 Dec;39(6):523-536. doi: 10.1007/s13402-016-0294-4. Epub 2016 Aug 25. Cell Oncol (Dordr). 2016. PMID: 27562587
-
In vitro Cytotoxic Screening of Different Parts from Ornithogalum bungei on Selected Cancer Cells.Iran J Med Sci. 2022 Jan;47(1):63-72. doi: 10.30476/IJMS.2021.89521.2037. Iran J Med Sci. 2022. PMID: 35017779 Free PMC article.
-
Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.Cell Oncol (Dordr). 2016 Jun;39(3):253-63. doi: 10.1007/s13402-016-0270-z. Epub 2016 Feb 26. Cell Oncol (Dordr). 2016. PMID: 26920031
References
-
- A. Geurts van Kessel, The cancer genome: from structure to function. Cell Oncol 37, 155–165 (2014) - PubMed
-
- C. Santos, C. Sanz-Pamplona, E. Nadal, et al., Intrinsic cancer subtypes. Next steps into personalized medicine. Cell Oncol. 38(1) (2015). doi: 10.1007/s13402-014-0203-7 - PubMed
-
- M. Vitiello, L. Poliseno, Long non coding RNAs in cancer: implications for personalised therapy. Cell Oncol. 38(1) (2015). doi: 10.1007/s13402-014-0180-x - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources